Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15712573rdf:typepubmed:Citationlld:pubmed
pubmed-article:15712573lifeskim:mentionsumls-concept:C0019112lld:lifeskim
pubmed-article:15712573lifeskim:mentionsumls-concept:C0023981lld:lifeskim
pubmed-article:15712573lifeskim:mentionsumls-concept:C1518527lld:lifeskim
pubmed-article:15712573lifeskim:mentionsumls-concept:C0215217lld:lifeskim
pubmed-article:15712573pubmed:issue6lld:pubmed
pubmed-article:15712573pubmed:dateCreated2005-2-16lld:pubmed
pubmed-article:15712573pubmed:abstractTextDaflon, a phlebotropic agent, is of proven efficacy in the treatment of various venous disorders. Although it has been tried in the treatment of haemorrhoids, its efficacy in alleviating various haemorrhoidal symptoms has not been assessed properly. The aim of this study was to confirm the efficacy of Daflon in the treatment of haemorrhoidal symptoms.lld:pubmed
pubmed-article:15712573pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15712573pubmed:languageenglld:pubmed
pubmed-article:15712573pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15712573pubmed:citationSubsetIMlld:pubmed
pubmed-article:15712573pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15712573pubmed:statusMEDLINElld:pubmed
pubmed-article:15712573pubmed:monthDeclld:pubmed
pubmed-article:15712573pubmed:issn1479-666Xlld:pubmed
pubmed-article:15712573pubmed:authorpubmed-author:MeshikhesA...lld:pubmed
pubmed-article:15712573pubmed:issnTypePrintlld:pubmed
pubmed-article:15712573pubmed:volume2lld:pubmed
pubmed-article:15712573pubmed:ownerNLMlld:pubmed
pubmed-article:15712573pubmed:authorsCompleteYlld:pubmed
pubmed-article:15712573pubmed:pagination335-8, 361lld:pubmed
pubmed-article:15712573pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15712573pubmed:meshHeadingpubmed-meshheading:15712573...lld:pubmed
pubmed-article:15712573pubmed:meshHeadingpubmed-meshheading:15712573...lld:pubmed
pubmed-article:15712573pubmed:meshHeadingpubmed-meshheading:15712573...lld:pubmed
pubmed-article:15712573pubmed:meshHeadingpubmed-meshheading:15712573...lld:pubmed
pubmed-article:15712573pubmed:meshHeadingpubmed-meshheading:15712573...lld:pubmed
pubmed-article:15712573pubmed:meshHeadingpubmed-meshheading:15712573...lld:pubmed
pubmed-article:15712573pubmed:meshHeadingpubmed-meshheading:15712573...lld:pubmed
pubmed-article:15712573pubmed:meshHeadingpubmed-meshheading:15712573...lld:pubmed
pubmed-article:15712573pubmed:meshHeadingpubmed-meshheading:15712573...lld:pubmed
pubmed-article:15712573pubmed:meshHeadingpubmed-meshheading:15712573...lld:pubmed
pubmed-article:15712573pubmed:meshHeadingpubmed-meshheading:15712573...lld:pubmed
pubmed-article:15712573pubmed:year2004lld:pubmed
pubmed-article:15712573pubmed:articleTitleDaflon for haemorrhoids: a prospective, multi-centre observational study.lld:pubmed
pubmed-article:15712573pubmed:affiliationDepartment of Surgery, Dammam Central Hospital, Dammam, Eastern Province, Saudi Arabia. meshikhes@doctor.comlld:pubmed
pubmed-article:15712573pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15712573pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:15712573pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:15712573pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15712573lld:pubmed